Does BRODALUMAB Cause Therapy cessation? 89 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 89 reports of Therapy cessation have been filed in association with BRODALUMAB (Siliq). This represents 4.3% of all adverse event reports for BRODALUMAB.
89
Reports of Therapy cessation with BRODALUMAB
4.3%
of all BRODALUMAB reports
2
Deaths
24
Hospitalizations
How Dangerous Is Therapy cessation From BRODALUMAB?
Of the 89 reports, 2 (2.2%) resulted in death, 24 (27.0%) required hospitalization.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BRODALUMAB. However, 89 reports have been filed with the FAERS database.
What Other Side Effects Does BRODALUMAB Cause?
Psoriasis (418)
Drug ineffective (177)
Arthralgia (175)
Fatigue (152)
Psoriatic arthropathy (141)
Intentional product use issue (136)
Headache (126)
Therapy interrupted (126)
Product dose omission issue (124)
Disease recurrence (118)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ADALIMUMAB (1,712)
ABIRATERONE (1,602)
VOXELOTOR (1,038)
CLOZAPINE (885)
LOMITAPIDE (828)
CAPECITABINE (746)
TREPROSTINIL (743)
ISOTRETINOIN (633)
Which BRODALUMAB Alternatives Have Lower Therapy cessation Risk?
BRODALUMAB vs BROLUCIZUMAB
BRODALUMAB vs BROLUCIZUMAB-DBLL
BRODALUMAB vs BROMAZEPAM
BRODALUMAB vs BROMFENAC
BRODALUMAB vs BROMHEXINE